Quality assured
Confidentiality assured
Custom research services
The global pharmaceutical plastic packaging market is set to grow at a robust pace. This report would reveal valuable insights into the global market, including market valuation, growth drivers, regional analysis, and key market players.
Market Analysis Brief
Of the entire market for pharmaceutical packaging that valuates at around US$100 Bn, the pharmaceutical plastic packaging market accounts for nearly half the revenue share. The global pharmaceutical plastic packaging market size is all set for tremendous growth in the years to come, which is majorly attributed to the burgeoning expansion of the pharmaceutical industry. Furthermore, the massive growth of the pharmaceutical business due to the rise in chronic diseases such as cancer, diabetes, and cardiovascular diseases is extending the growth ambits of the market. The ongoing technological and scientific development shall further fuel the growth of the global market. Anticipating these trends, the coming years shall create positive tides for the global pharmaceutical plastic packaging industry.
Key Report Findings
Growth Drivers
Cutting-edge Technological Advancements
Nano-drug delivery systems leverage advanced technologies that utilise nanoparticles, ensuring the targeted delivery and controlled release of therapeutic agents. This modern technology, in its development stage, can be potentially used in treatment for cancer, cardiovascular diseases, diabetes, and various microbial and inflammatory diseases. In addition, nanotechnology provides various benefits during the treatment of chronic ailments such as cardiovascular diseases (CVDs). This is facilitated by site-specific and target-oriented delivery of drugs.
To avert the risk of children handling, opening, and ingesting dangerous items, child-resistant packaging (CRP) is extensively used. Regulatory compliance for prescription drugs, nicotine-based products, and over-the-counter medications is a critical enabler of the scaled adoption of CRP. Various developed countries have mandated the use of CRP for drugs such as aspirin, contraceptive pills, paracetamol, elemental iron, and others. This complements the growth of the pharmaceutical plastic packaging market to a large extent.
Accentuation on Primary Pharmaceutical Packaging
Primary pharmaceutical packaging solutions are regarded as products that come in immediate contact with medicine or drugs. Plastic bottles, prefilled syringes, glass bottles, pre-filled inhalers, blister packaging, and medication tubes among others are a few types of packaging options available in the market. The global pharmaceutical plastic packaging market is majorly driven by the growing demand for pre-fillable syringes and pre-fillable inhalers.
Moreover, blister packs, plastic bottles, and ampoules and vials are a few prominent primary pharmaceutical packaging that is growing at breakneck speed. During the forecast period, innovations in biotechnology responsible for the development of new injectable parenteral therapies and accelerated demand for high visibility unit dosage packaging for diseases including diabetes shall nurture a strong base for the global market, generating substantial business opportunities for market players.
Plastics Remains an Ideal Raw Material
Considering the type of raw material used, plastic paces ahead of the competition in the pharmaceutical plastic packaging market owing to design flexibility and greater affordability of the packaging solution. This makes it a perfect fit for pharmaceutical packaging. The material stands out due to its impeccable properties including rigidity, strength, shatter resistance, moldability, and light-weighting.
The superior shatter resistance makes it suitable for transportation and provides ease of handling goods during the transition. The ease of moulding offered by plastic further adds the strength and efficiency necessary for shielding in vapour, and gas.
Overview of Key Segments
Plastic Bottles Segment Holds a Major Market Share
The most popular type of packaging item for packaging pharmaceuticals is plastic bottles. These types of packaging items are ideal for storing drugs in liquid and solid forms. Based on certain applications, these plastic bottles can be aligned with an apt type of cap and closure nasal, for instance, nasal spray, and ophthalmic drops.
Various types of packaging relevant to plastic bottles include sterile packaging for blood and related components, rigid form for solid dosages, squeezable bottles, and jars. With more patient compliance and convenience with oral drug delivery, the growing pervasiveness of communicable diseases, and the rise in the geriatric population in established economies are highlighting the prominence of the plastic bottles segment in the pharmaceutical plastic packaging market.
Nasal Drugs to Spearhead Dominance
Normally, nasal drugs are in liquid form. Yet, it is also available in powder form, offering higher stability and facilitating new device developments, developing a promising growth trajectory. Nasal drug delivery containers are also referred to as nasal sprays. Compression of therapeutically active ingredients dissolved in solutions or mixtures of excipients in non-pressurized dispensers ensures a metered dose of the active ingredient. These doses are either metered by the spray pump or pre-meted during manufacture.
Growth Opportunities Across Regions
North America Reigns Supreme amid Extensive In-house Production
Being a hub for pharma manufacturing, assimilating in-house production as the largest end-use segment, North America is set for boisterous growth. During the period of assessment, the region is likely to lead with an expansive pool of manufacturers of pharmaceutical plastic bottles, satiating the ever-growing demand for pharmaceutical plastic bottles.
On the flip side, Asia Pacific is projected to register the fastest growth attributed to growing awareness among consumers and rising disposable income levels, particularly in China, and India. Heightened government initiatives, expanding pharmaceutical contract manufacturing activities, and a growing geriatric population is expected to promote the pharmaceutical plastic packaging market in the region.
Leading Industry Participants
Some of the most competitive players in the global pharmaceutical plastic packaging market include Amcor plc, Becton, Dickinson, and Company, AptarGroup, Inc., Drug Plastics Group, Gerresheimer AG, Schott AG, Owens Illinois, Inc., West Pharmaceutical Services, Inc., Berry Global, Inc., WestRock Company, SGD Pharma, International Paper, Comar, LLC, CCL Industries, Inc., and Vetter Pharma International.
These players are undertaking robust initiatives such as M&A and emphasizing the development of innovative products to expand market penetration.
Regional Classification of the Global Pharmaceutical Plastic Packaging Market is Listed Below:
North America
Europe
Asia Pacific
Latin America
Middle East and Africa
1. Executive Summary
1.1. Global Pharmaceutical Plastic Packaging Market Snapshot
1.2. Key Market Trends
1.3. Future Projections
1.4. Analyst Recommendations
2. Market Overview
2.1. Market Definitions and Segmentations
2.2. Market Dynamics
2.2.1. Drivers
2.2.1.1. Driver A
2.2.1.2. Driver B
2.2.1.3. Driver C
2.2.2. Restraints
2.2.2.1. Restraint 1
2.2.2.2. Restraint 2
2.2.3. Market Opportunities Matrix
2.3. Value Chain Analysis
2.4. Porter’s Five Forces Analysis
2.5. Covid-19 Impact Analysis
2.5.1. Pre-covid and Post-covid Scenario
2.5.2. Supply Impact
2.5.3. Demand Impact
2.6. Government Regulations
2.7. Share of Pharmaceutical Plastic Packaging in Parent Market
2.8. Substitution Analysis
2.9. Impact of Serialization on Pharmaceutical Packaging
2.10. Biodegradable and Sustainable Plastic Solutions
2.10.1. Recycled Plastics
2.10.2. Polylactic Acid
2.10.3. Biodegradable Plastics
2.11. Economic Analysis
3. Production Output and Trade Statistics, 2018 - 2021
3.1. Packaging Supply-Demand Analysis
3.2. Regional Production Statistics
3.2.1. North America
3.2.2. Europe
3.2.3. Asia Pacific
3.2.4. Latin America
3.2.5. Middle East & Africa
4. Price Trends Analysis and Future Projects, 2018 - 2030
4.1. Key Highlights
4.2. Prominent Factors Affecting Prices
4.3. By Material
4.4. By Region
5. Global Pharmaceutical Plastic Packaging Market Outlook, 2018 - 2030
5.1. Global Pharmaceutical Plastic Packaging Market Outlook, by Material, Volume (Kilo Tons) and Value (US$ Mn), 2018 - 2030
5.1.1. Key Highlights
5.1.1.1. Polypropylene
5.1.1.2. Polyethylene Terephthalate
5.1.1.3. High-density Polyethylene
5.1.1.4. Low-density Polyethylene
5.1.1.5. Polyvinyl Chloride
5.1.1.6. Biobased Plastics
5.1.1.7. Misc. (Polycarbonate, ABS, etc.)
5.1.2. BPS Analysis/Market Attractiveness Analysis
5.2. Global Pharmaceutical Plastic Packaging Market Outlook, by Applications, Volume (Kilo Tons) and Value (US$ Mn), 2018 - 2030
5.2.1. Key Highlights
5.2.1.1. Bottle & Jars
5.2.1.2. Blister Packs
5.2.1.3. Prefillable Syringes
5.2.1.4. Pouches & Sachets
5.2.1.5. Vials
5.2.1.6. Ampoules
5.2.1.7. Misc. (Prefillable Inhalers, etc.)
5.2.2. BPS Analysis/Market Attractiveness Analysis
5.3. Global Pharmaceutical Plastic Packaging Market Outlook, by Region, Volume (Kilo Tons) and Value (US$ Mn), 2018 - 2030
5.3.1. Key Highlights
5.3.1.1. North America
5.3.1.2. Europe
5.3.1.3. Asia Pacific
5.3.1.4. Latin America
5.3.1.5. Middle East & Africa
5.3.2. BPS Analysis/Market Attractiveness Analysis
6. North America Pharmaceutical Plastic Packaging Market Outlook, 2018 - 2030
6.1. North America Pharmaceutical Plastic Packaging Market Outlook, by Material, Volume (Kilo Tons) and Value (US$ Mn), 2018 - 2030
6.1.1. Key Highlights
6.1.1.1. Polypropylene
6.1.1.2. Polyethylene Terephthalate
6.1.1.3. High-density Polyethylene
6.1.1.4. Low-density Polyethylene
6.1.1.5. Polyvinyl Chloride
6.1.1.6. Biobased Plastics
6.1.1.7. Misc. (Polycarbonate, ABS, etc.)
6.2. North America Pharmaceutical Plastic Packaging Market Outlook, by Application, Volume (Kilo Tons) and Value (US$ Mn), 2018 - 2030
6.2.1. Key Highlights
6.2.1.1. Bottle & Jars
6.2.1.2. Blister Packs
6.2.1.3. Prefillable Syringes
6.2.1.4. Pouches & Sachets
6.2.1.5. Vials
6.2.1.6. Ampoules
6.2.1.7. Misc. (Prefillable Inhalers, etc.)
6.3. North America Pharmaceutical Plastic Packaging Market Outlook, by Country, Volume (Kilo Tons) and Value (US$ Mn), 2018 - 2030
6.3.1. Key Highlights
6.3.1.1. U.S.
6.3.1.2. Canada
6.3.2. BPS Analysis/Market Attractiveness Analysis
7. Europe Pharmaceutical Plastic Packaging Market Outlook, 2018 - 2030
7.1. Europe Pharmaceutical Plastic Packaging Market Outlook, by Material, Volume (Kilo Tons) and Value (US$ Mn), 2018 - 2030
7.1.1. Key Highlights
7.1.1.1. Polypropylene
7.1.1.2. Polyethylene Terephthalate
7.1.1.3. High-density Polyethylene
7.1.1.4. Low-density Polyethylene
7.1.1.5. Polyvinyl Chloride
7.1.1.6. Biobased Plastics
7.1.1.7. Misc. (Polycarbonate, ABS, etc.)
7.1.2. BPS Analysis/Market Attractiveness Analysis
7.2. Europe Pharmaceutical Plastic Packaging Market Outlook, by Application, Volume (Kilo Tons) and Value (US$ Mn), 2018 - 2030
7.2.1. Key Highlights
7.2.1.1. Bottle & Jars
7.2.1.2. Blister Packs
7.2.1.3. Prefillable Syringes
7.2.1.4. Pouches & Sachets
7.2.1.5. Vials
7.2.1.6. Ampoules
7.2.1.7. Misc. (Prefillable Inhalers, etc.)
7.3. Europe Pharmaceutical Plastic Packaging Market Outlook, by Country, Volume (Kilo Tons) and Value (US$ Mn), 2018 - 2030
7.3.1. Key Highlights
7.3.1.1. Germany
7.3.1.2. France
7.3.1.3. U.K.
7.3.1.4. Italy
7.3.1.5. Spain
7.3.1.6. Turkey
7.3.1.7. Russia
7.3.1.8. Rest of Europe
7.3.2. BPS Analysis/Market Attractiveness Analysis
8. Asia Pacific Pharmaceutical Plastic Packaging Market Outlook, 2018 - 2030
8.1. Asia Pacific Pharmaceutical Plastic Packaging Market Outlook, by Material, Volume (Kilo Tons) and Value (US$ Mn), 2018 - 2030
8.1.1. Key Highlights
8.1.1.1. Polypropylene
8.1.1.2. Polyethylene Terephthalate
8.1.1.3. High-density Polyethylene
8.1.1.4. Low-density Polyethylene
8.1.1.5. Polyvinyl Chloride
8.1.1.6. Biobased Plastics
8.1.1.7. Misc. (Polycarbonate, ABS, etc.)
8.2. Asia Pacific Pharmaceutical Plastic Packaging Market Outlook, by Application, Volume (Kilo Tons) and Value (US$ Mn), 2018 - 2030
8.2.1. Key Highlights
8.2.1.1. Bottle & Jars
8.2.1.2. Blister Packs
8.2.1.3. Prefillable Syringes
8.2.1.4. Pouches & Sachets
8.2.1.5. Vials
8.2.1.6. Ampoules
8.2.1.7. Misc. (Prefillable Inhalers, etc.)
8.3. Asia Pacific Pharmaceutical Plastic Packaging Market Outlook, by Country, Volume (Kilo Tons) and Value (US$ Mn), 2018 - 2030
8.3.1. Key Highlights
8.3.1.1. China
8.3.1.2. Japan
8.3.1.3. South Korea
8.3.1.4. India
8.3.1.5. Southeast Asia
8.3.1.6. Rest of Asia Pacific
8.3.2. BPS Analysis/Market Attractiveness Analysis
9. Latin America Pharmaceutical Plastic Packaging Market Outlook, 2018 - 2030
9.1. Latin America Pharmaceutical Plastic Packaging Market Outlook, by Material, Volume (Kilo Tons) and Value (US$ Mn), 2018 - 2030
9.1.1. Key Highlights
9.1.1.1. Polypropylene
9.1.1.2. Polyethylene Terephthalate
9.1.1.3. High-density Polyethylene
9.1.1.4. Low-density Polyethylene
9.1.1.5. Polyvinyl Chloride
9.1.1.6. Biobased Plastics
9.1.1.7. Misc. (Polycarbonate, ABS, etc.)
9.2. Latin America Pharmaceutical Plastic Packaging Market Outlook, by Application, Volume (Kilo Tons) and Value (US$ Mn), 2018 - 2030
9.2.1. Key Highlights
9.2.1.1. Bottle & Jars
9.2.1.2. Blister Packs
9.2.1.3. Prefillable Syringes
9.2.1.4. Pouches & Sachets
9.2.1.5. Vials
9.2.1.6. Ampoules
9.2.1.7. Misc. (Prefillable Inhalers, etc.)
9.3. Latin America Pharmaceutical Plastic Packaging Market Outlook, by Country, Volume (Kilo Tons) and Value (US$ Mn), 2018 - 2030
9.3.1. Key Highlights
9.3.1.1. Brazil
9.3.1.2. Mexico
9.3.1.3. Rest of Latin America
9.3.2. BPS Analysis/Market Attractiveness Analysis
10. Middle East & Africa Pharmaceutical Plastic Packaging Market Outlook, 2018 - 2030
10.1. Middle East & Africa Pharmaceutical Plastic Packaging Market Outlook, by Material, Volume (Kilo Tons) and Value (US$ Mn), 2018 - 2030
10.1.1. Key Highlights
10.1.1.1. Polypropylene
10.1.1.2. Polyethylene Terephthalate
10.1.1.3. High-density Polyethylene
10.1.1.4. Low-density Polyethylene
10.1.1.5. Polyvinyl Chloride
10.1.1.6. Biobased Plastics
10.1.1.7. Misc. (Polycarbonate, ABS, etc.)
10.2. Middle East & Africa Pharmaceutical Plastic Packaging Market Outlook, by Application, Volume (Kilo Tons) and Value (US$ Mn), 2018 - 2030
10.2.1. Key Highlights
10.2.1.1. Bottle & Jars
10.2.1.2. Blister Packs
10.2.1.3. Prefillable Syringes
10.2.1.4. Pouches & Sachets
10.2.1.5. Vials
10.2.1.6. Ampoules
10.2.1.7. Misc. (Prefillable Inhalers, etc.)
10.2.2. BPS Analysis/Market Attractiveness Analysis
10.3. Middle East & Africa Pharmaceutical Plastic Packaging Market Outlook, by Country, Volume (Kilo Tons) and Value (US$ Mn), 2018 - 2030
10.3.1. Key Highlights
10.3.1.1. GCC
10.3.1.2. South Africa
10.3.1.3. Rest of Middle East & Africa
10.3.2. BPS Analysis/Market Attractiveness Analysis
11. Competitive Landscape
11.1. Company Market Share Analysis, 2021
11.2. Competitive Dashboard
11.3. Product vs Application Heatmap
11.4. Company Profiles
11.4.1. Amcor Plc
11.4.1.1. Company Overview
11.4.1.2. Product Portfolio
11.4.1.3. Financial Overview
11.4.1.4. Business Strategies and Development
(*Note: Above details would be available for below list of companies based on availability)
11.4.2. WestRock Company SGD S.A.
11.4.3. Becton Dickinson and Company
11.4.4. Berry Global Group, Inc
11.4.5. Mondi group
11.4.6. Sealed Air Corporation
11.4.7. Gerresheimer Group
11.4.8. Nipro Corporation
11.4.9. Gilpack
11.4.10. Catalent, Inc.
11.4.11. West Pharmaceutical Services, Inc.
11.4.12. UDG Healthcare
11.4.13. AptarGroup Inc.
12. Appendix
12.1. Research Methodology
12.2. Report Assumptions
12.3. Acronyms and Abbreviations
Considering the volatility of business today, traditional approaches to strategizing a game plan can be unfruitful if not detrimental. True ambiguity is no way to determine a forecast. A myriad of predetermined factors must be accounted for such as the degree of risk involved, the magnitude of circumstances, as well as conditions or consequences that are not known or unpredictable. To circumvent binary views that cast uncertainty, the application of market research intelligence to strategically posture, move, and enable actionable outcomes is necessary.
View Methodology
Quality assured
Confidentiality assured
Custom research services
